Menu
GeneBe

rs864309548

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_001271.4(CHD2):c.4921C>T(p.Gln1641Ter) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)

Consequence

CHD2
NM_001271.4 stop_gained

Scores

5
1
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3O:1

Conservation

PhyloP100: 5.46
Variant links:
Genes affected
CHD2 (HGNC:1917): (chromodomain helicase DNA binding protein 2) The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-93020026-C-T is Pathogenic according to our data. Variant chr15-93020026-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 218399.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CHD2NM_001271.4 linkuse as main transcriptc.4921C>T p.Gln1641Ter stop_gained 38/39 ENST00000394196.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CHD2ENST00000394196.9 linkuse as main transcriptc.4921C>T p.Gln1641Ter stop_gained 38/395 NM_001271.4 P1O14647-1
CHD2ENST00000626874.2 linkuse as main transcriptc.4921C>T p.Gln1641Ter stop_gained 38/381 O14647-2
CHD2ENST00000625662.3 linkuse as main transcriptc.*1092C>T 3_prime_UTR_variant, NMD_transcript_variant 34/355
CHD2ENST00000627460.1 linkuse as main transcriptc.*53C>T 3_prime_UTR_variant, NMD_transcript_variant 4/55

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
35
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy 94 Pathogenic:3Other:1
Pathogenic, criteria provided, single submitterresearchCavalleri Lab, Royal College of Surgeons in IrelandDec 11, 2019ACMG evidence PVS1,PS2,PM2, PP2, PP5 -
not provided, no classification providedphenotyping onlyDepartment of Developmental Neurology, Medical University of Gdańsk-- -
Pathogenic, criteria provided, single submitterclinical testingDASAJan 05, 2022The c.4921C>T;p.(Gln1641*) variant creates a premature translational stop signal in the the CHD2 gene. It is expected to result in an absent or disrupted protein product -PVS1.This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 218399; PMID: 25418537; 32238909) - PS4_modetare. This variant is not present in population databases (rs864309548, gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. The variant was assumed de novo, but without confirmation of paternity and maternity (PMID: 32238909) - PM6. In summary, the currently available evidence indicates that the variant is pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingInvitaeFeb 26, 2023For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 218399). This sequence change creates a premature translational stop signal (p.Gln1641*) in the CHD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHD2 are known to be pathogenic (PMID: 23708187, 24207121). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autism spectrum disorder and/or epileptic encephalopathy (PMID: 25418537, 28191889, 31981491, 32238909). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.58
Cadd
Pathogenic
48
Dann
Uncertain
1.0
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.89
FATHMM_MKL
Pathogenic
0.98
D
MutationTaster
Benign
1.0
A;D
Vest4
0.73
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs864309548; hg19: chr15-93563256; API